Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We have an amazing team put together now and proven products about to be sold. Expect great longterm growth here for years to come. Take a position your comfortable with and don't worry about the day to day trading. The owners did not sell there stock when it was $2 and $3 because they believe there products longterm will be billion dollar products. Go to there website and research there team and products, compare it to other companies and you will find we are about to be come a big player in this new industry.
Read there filings:
I can lead a horse to water but I can't make it drink. Read the last sentence of this PR
The Company expects that its Topical Cream will be Market-Ready in Q2 2017
PETACH TIKVA, Israel, March _____, 2017 /PRNewswire /OWC Pharmaceutical Research Corp. (OTCQB: OWCP), ("OWC" or the "Company"), an Israeli-based developer of cannabinoid-based therapies targeting a variety of medical conditions and disorders, today announced the highly promising results of its topical cream efficacy tests following months of study and scientific analysis.
In October 2016, OWC announced that it was in the final phase of pre-clinical efficacy testing for its topical psoriasis cream and also announced a parallel test to assess the efficacy of the formulation in treating psoriasis in human skin tissue. The recent results are highly promising, showing significant reduction of several inflammation markers specific to psoriasis.
As a result of the promising results of our psoriasis tests, our Chairman and CEO, Mr. Mordechai Bignitz, has directed OWC's scientific team to submit an operating plan within 60 to 90 days to conduct double-blind efficacy tests of our cannabinoid-based topical cream on other skin disorders and conditions
Dr. Yehuda Baruch, the Company's Chief Science Officer and Director of Research and Regulatory Affairs, commented "As a practicing physician and a scientist who has been treating patients with cannabis for medical purposes for more than two decades, I am truly excited by our success to date and, more importantly, I am thrilled to be part of a professional scientific study on humans that should actually validate what I have believed and experienced for years - Cannabis helps treat a multitude of health conditions."
Dr. Sharon Rozenblat, PhD in Biochemistry, a member of OWC Scientific Advisory Board added, "After many years of being actively involved in research and development of innovative dermatological treatments and being exposed to the many scientific articles and peer reviewed works and publications regarding skin conditions and diseases, I would like to emphasize my personal belief that OWC's psoriasis results have been indeed unique in the most positive sense." Dr. Rozenblat continued by stating "while there is still scientific work to be done, as a scientist I am extremely excited to be part of OWC's study that appears to be a highly possible breakthrough that can improve the life of psoriasis patients and, possibly, patients with other skin conditions".
I made my first million not listening to propaganda and doing my proper DD when necessary. I suspect my second million will come much the same way. This is the best longterm Mmj biopharma company out there with great leaders and scientist now in charge. I can wait for 2018, 2019, and 2020. They will be epic for this company and there research. More news about to drop....
Tough day here, longterm we are still solid and that is the main thing!
Dr. Hirsch seems to know how good the cream is:
Dr. Stanley Hirsch commented on his new role “I feel privileged to have received the invitation to serve as OWCP’s active chairman. I have known Mr. Bignitz for more than 20 years and we cooperated extremely successfully in the past. I received an in depth scientific overview from OWCP’s CSO, Dr. Yehuda Baruch and I am sure OWCP’s intellectual assets and scientific achievements position it most advantageously to become a world leader in the field of Cannabis based scientific products.
So can someone tell me, what does Intiva do and bring to the table?
Something big happened last week in the L2. A few large buys came through, I would say there is definitely some good news this week.
I will and have constantly said, without sales news we will remain a vulnerable stock, pps could go either way.
What fake contracts? Please provide a link.
To hep put things in perspective for longs and newbies:
* We have an application for full IP . Less than handful applications for full IP had been filed for MMJ products
* we have pre-clinical efficacy study results that , to those that understand, are scientific breakthrough
* we have the first ever IRB approval for MMJ cream
* we have developed a unique sub-lingual tablet
* we have a MM study
And much more which part is public domain and most is still not I believe....
Management:
Our CSO is the former Israeli MMJ regulator . It will take many years to match his knowledge
Our CEO , chaired the biggest investment house in Israel and sat in the BOD of 2 successful biotech companies ( in fact he lead one Dr. Hirsch's previous exits ...)
Our CFO - left a Nasdaq company to Join OWCP ....
Our Chairman with PHD from oxford ...
Scientific & managerial expertise- directly related to our business
Advisory board , Dr. Rosenblatt, Mrs. Miri Sani = A Team
Show me one MMJ OTC company with a fraction of what we have ....and all that in just 3 years of operations!!
Think about what the next 3 years will bring!!
Yes sir! This a great longterm investment with great potential! Our new chairman has worked with Bayer through his other company FOMX. He's a big player for the company from here on out. Also Fomx wants to add another 40 million shares I believe and they have plenty of cash on hand. Something seems up with that? Maybe a deal with fomx and owcp of some kind in the works?
Owcp is in a great position! As time goes by the company becomes more valuable by the month! When our government eventually changes regulations and makes it legal in all 50 states, we will be top on the list for a buyout! Longs and patience will be rewarded here.
BOOM! Our new Chairman and CEO are working together trying to figure out the best method financially to get MM study into orphan drug! Exciting times ahead for shareholders and the lives this study can help!
OWCP$$$
This is way oversold, I expect a nice jump next week!
Lot of people were hollering .20, I had a $150,000.00 ready for that day to happen! But I'm agreeing with you, Looks like the reversal could be happening!
What did the ML guy say was going to happen today?
Germany, California, and Canada is where I know they've been, and a lot! You are making good points today!
In there filings, April 4th 8-k
This is a great post, and I think a lot of people don't realize it! Should be posted a couple times a week!
JUST a friendly reminder to all... product sales aren't what will kick off OWC revenue. Product Licensing will... OWC has made it clear they intend to license their IP... This could be any time now. Revenue in Q3 and Q4 will likely be royalties.
DR. BARUCH TO HEAD UP PSORIASIS STUDY IN 2018
A wide and in-depth multi-layer clinical study on Psoriasis and psychological aspects is targeted to start next year, 2018, after collection of data from patients to carefully plan the targets of such a unique study that will show a combination of cannabinoids treatments for a specific disease. The study is carefully managed by Dr. Yehuda Baruch, the Company's CSO & Director of Research and Regulatory Affairs. Dr. Baruch comments, "We started safety phase at the hospital by this month, April 2017, and already planning a unique multi-center efficacy study. This is the natural development of the next generation of safe and tested cannabinoids treatments".
Here I thought August 4th was your b-day:)!!!!
Good times ahead here!
I do not know the date, I'm guessing at some point in August.
OWCP about to get some world wide attention! Things are looking up!
MULTIPLE MYELOMA
cancer of plasma cells)
• Designed to be an Orphan Disease study approved by the FDA
• In-vitro study completed 06/2015 – Cannabis kills the MM cancer cells
• Pre-clinic study on mice completed 12/2015 – calibration phase for dosage, found most effective ratio of active cannabinoids THC/CBD
• In-vitro study for a combination of 4 approved drugs with cannabis completed 05/2016 – promising results
• Pre-clinic study for the most effective combination on mice with new cannabis extracts. On-going testing.
• SUBJECT TO ACHIEVING SCIENTIFIC MILESTONES THE COMPANY WILL SUBMITT AN APPLICATION WITH THE FDA FOR AN ORPHAN DISEASE DESIGNATION
We are down to the best delivery system now, oral or a suppository and this ends in Q3.....
Feeling good about the longterm future here!
You know it all right!!$$$
There were big buys that came in today and I haven't seen that in a very long time! Volume didn't necessarily show it, but the L2 did. Something big is up and a very few know it as of yet.
Well where in the companies filings say sales wouldn't start for 6 to 9 months? The sell off probably did come from mediq saying that. But wait, did they really? Or did someone misinterpret there conversation with Jeff Furst or purposely lie for there own gains?
Here's what I know about what Jeff Furst was saying and I've never posted this before.
He was not disclosing timelines about when sales of the cream would start, he was speaking of timelines within his own staff and how to handle the sales coming. He's amazingly excited about the future of OWCP.
Thank you to all the people who believed the post that were produced, I picked up some cheap shares this week!
OWCP official filings will tell you what you need to know, all you have to do is read them:
When in doubt, be half right or half wrong..... buy half of what you want is what I'm saying. JMO
Nice 233000 share bid at .36 indeed:)
I agree with your statements and expect to hear on both them fronts this month.
RSI sitting low, this could really run for awhile with some good news! Great entry point!
Lots of good things in here, take a look if you haven't yet.
http://www.owcpharma.com/wp-content/uploads/2017/07/OWCP-July2017.pdf
There credibility will not exist when this becomes a leader in this industry, and we are not far from that with cream and sublingual tablet sales about to start. Then throw MM into it all moving to orphan drug and life as a OWCP shareholder is good:)
I would like to see a patent application filed in Canada and other countries if necessary , its an easy way to track where we are looking to do business with and sharing our IP
What does that mean?
If it were a scam there shares would've been sold at $2 and $3. Instead they all have there shares as they know longterm the pps will be well above that with there products.
Best of luck and keep an eye on this!
I think most investors thought market ready in q2 would mean sales would be happening. I think until some sort of sales/manufacturing JV deal is officially announced the stock remains vulnerable. Lots of investors sitting on the sidelines until that's announced , and lots of them sold which drove the price down. That's part of it, probably not all of it. JMO
I think you and are on the same page here so I'm going to post this again.
So here we are thinking of sales coming for psoriasis and the sublingual tablet. Then Dr. Hirsch gets appointed active chairman. If you don't know the difference between a chairman and CEO I suggest you google it, because there is a difference. But I feel something could be coming we least expected here?? Read my thoughts and come to your own conclusions. Another person on the other board recognized this also.
The most interesting thing I've found about our new chairman, is the company he's with FOMX, is in a phase 3 trial for acne that just failed in march. From what I've read the company still hasn't declared a clear path of moving forward to get past the trial. I think most investors know when OWCP announced the cream could be used for other uses that acne was one one of them, it just hasn't been officially announced. FOMX also has ties to Bayer with there drug, and other dermatology drugs FOMX has.
Long story short here, connect the dots, I think we've found a partner in getting our acne cream out to the world..... something none of us seen coming.
This is just my opinion, but makes a lot of sense.
https://seekingalpha.com/article/4059298-foam...sis-killer
(0) (0)
MEDMAR was denied a license to sell mmj that they applied for, why wouldn't we cut ties.
I also picked up on there failed drug for acne. One of the thoughts for another use for our cream has been acne, so there's a definite connection there going on. This is getting interesting all of the sudden to say the least. Let's look for an announcement someday soon for an acne study possibly funded by FOMX??? Just connecting some dots here!
Have a great weekend all!